Vifor Pharma (United States)

Relaxation and immunity enhancement effects of γ‐Aminobutyric acid (GABA) administration in humans

Adham M. Abdou, S. Higashiguchi, Kenji Horie et al. · BioFactors · 2006 · 398 citations

Association of Serum Potassium with All-Cause Mortality in Patients with and without Heart Failure, Chronic Kidney Disease, and/or Diabetes

Allan J. Collins, Bertram Pitt, Nancy L. Reaven et al. · American Journal of Nephrology · 2017 · 384 citations · Full text

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial

Rajiv Agarwal, Patrick Rossignol, Alain Romero et al. · The Lancet · 2019 · 351 citations

Hypertension, Patiromer Versus Placebo, Cardiovascular Disease +10

Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines

Chun Wang, Qing Ge, David T. Ting et al. · Nature Materials · 2004 · 258 citations

Nanomedicine, Engineering, Ortho Ester +10

Genotypes and phenotypes in children with short stature: clinical indicators of <i>SHOX</i> haploinsufficiency

Gudrun Rappold, W. F. Blum, Elena P. Shavrikova et al. · Journal of Medical Genetics · 2006 · 254 citations · Full text